Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, HER2/EGFR in Cancer Research, Pancreatic and Hepatic Oncology Research, and Growth Hormone and Insulin-like Growth Factors.
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood–tumor barrier disruption
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium
A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors.
CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer
Solid stress and elastic energy as measures of tumour mechanopathology
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis
Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study.
PubMed 2015cited by 39position: middle
Screening of a Novel Peptide Targeting the Proteoglycan-Like Region of Human Carbonic Anhydrase IX
Peptide Arrays for Development of PDGFRβ Affine Molecules
Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial
Antitumor Effects of Proteasome Inhibition in Anaplastic Thyroid Carcinoma
Peptide-Based Targeting of the Platelet-Derived Growth Factor Receptor Beta
Optimization of a Novel Peptide Ligand Targeting Human Carbonic Anhydrase IX